Gilead Sciences Inc sell Trip
Start price
05.01.21
/
50%
€48.93
Target price
05.01.22
-
Performance (%)
10.78%
End price
03.06.21
€54.20
Summary
This prediction ended on 03.06.21 with a price of €54.20. The SELL prediction by Trip finished with a performance of 10.78%. Dividends of €0.59 are taken into consideration when calculating the performance. Trip has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -1.199% | -1.199% | -20.533% | 15.706% |
iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to Trip what are the pros and cons of Gilead Sciences Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Future proof or reliable business model
Cons
Comments by Trip for this prediction
In the thread Gilead Sciences Inc diskutieren
Sell Gilead Sciences Inc
In the thread Trading Gilead Sciences Inc
Sell beendet
Stopped prediction by Trip for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€58.10
18.08.20
18.08.20
-
04.11.21
04.11.21
-12.10%
11.11.20
11.11.20
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3